All Stories

Regeneron’s $256M bid wins 23andMe bankruptcy auction

The drugmaker Regeneron has won a bankruptcy auction for 23andMe and its DNA database gathered from some 15 million customers.

May 19, 2025 - 16:10
 0
Regeneron’s $256M bid wins 23andMe bankruptcy auction
The drugmaker Regeneron has won a bankruptcy auction for 23andMe and its DNA database gathered from some 15 million customers.
Read More

Tags:

Previous Article

Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant

Next Article

'Not game-changing': Boehringer's phase 3 lung data get muted response from anal...

Related Posts

RA Capital’s biotech incubator lays off staffers: Stat

RA Capital’s biotech incubator lays off staffers: Stat

May 14, 2025  0

VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey

VC firm reveals plan for 30K-square-foot biotech incuba...

May 15, 2025  0

GSK pays $1.2B upfront for Boston Pharmaceuticals’ lead liver disease drug

GSK pays $1.2B upfront for Boston Pharmaceuticals’ lead...

May 14, 2025  0